Neuroimaging of the vulnerable plaque.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24188487)

Published in Curr Vasc Pharmacol on January 01, 2015


Karl-Olof Lovblad1, Vitor Mendes-Pereira, Valentina Garibotto, Frederic Assal, Jean-Pierre Willi, Roman Stztajzel, Osman Ratib, Maria Isabel Vargas

Author Affiliations

1: Department of Interventional and Diagnostic Neuroradiology, Geneva University Hospitals, 4 rue Gabrielle- Perret-Gentil, 1211 Geneva 14, Switzerland.

Articles cited by this

Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33

Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58

Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet (1998) 10.64

Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet (2010) 7.62

Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet (2001) 5.82

Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. AJNR Am J Neuroradiol (2002) 2.06

Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol (2012) 1.82

The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke (2005) 1.70

Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging (2009) 1.66

Computed tomography in acute ischemic stroke. Neuroradiology (2009) 1.64

Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg (2008) 1.38

FDG-PET imaging of atherosclerosis: Do we know what we see? Atherosclerosis (2010) 1.01

Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging. Stroke (2009) 0.97

When to image carotid plaque inflammation with FDG PET/CT. Nucl Med Commun (2010) 0.94

Neuro-imaging of cerebral ischemic stroke. J Neuroradiol (2008) 0.91

Vascular imaging with positron emission tomography. J Intern Med (2011) 0.89

The use of positron emission tomography in cerebrovascular disease. Neuroimaging Clin N Am (2003) 0.88

Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques. AJNR Am J Neuroradiol (2011) 0.87

Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque. J Vasc Surg (2008) 0.87

Natural history and management of the asymptomatic, moderately stenotic internal carotid artery. J Vasc Surg (1997) 0.82

A PET-MRI case of corticocerebellar diaschisis after stroke. Clin Nucl Med (2011) 0.82

Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography. Geriatr Gerontol Int (2010) 0.81

Accuracy of a novel risk index combining degree of stenosis of the carotid artery and plaque surface echogenicity. Stroke (2012) 0.79

Carotid artery stenting: rationale, technique, and current concepts. Eur J Radiol (2010) 0.79

ADC mapping of chronic cerebral hypoperfusion induced by carotid artery stenosis. J Neuroradiol (2011) 0.79

Visual analysis or semi-automated gray-scale-based color mapping of the carotid plaque: which method correlates the best with the presence of cerebrovascular symptoms and/or lesions on MRI? J Neuroimaging (2008) 0.78

Magnetic resonance imaging of vascular diseases of the white matter. Top Magn Reson Imaging (2009) 0.77

[State of the art: high resolution MR imaging of carotid atherosclerotic plaque]. J Radiol (2010) 0.77

Articles by these authors

OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging (2004) 11.92

Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone (2009) 2.44

Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer. Eur J Nucl Med Mol Imaging (2012) 2.23

Cardiac MR imaging: state of the technology. Radiology (2006) 2.00

(11)C-acetate PET in the early evaluation of prostate cancer recurrence. Eur J Nucl Med Mol Imaging (2006) 1.79

Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging (2008) 1.76

Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study. J Gastroenterol Hepatol (2011) 1.57

Impedance monitoring during catheter ablation of atrial fibrillation. Heart Rhythm (2005) 1.49

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability. Thromb Haemost (2011) 1.48

Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol (2007) 1.42

Radiologic patterns of necrosis after proton therapy of skull base tumors. Can J Neurol Sci (2013) 1.41

Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med (2004) 1.37

Gait variability among healthy adults: low and high stride-to-stride variability are both a reflection of gait stability. Gerontology (2009) 1.31

Integration of a multimedia teaching and reference database in a PACS environment. Radiographics (2002) 1.27

Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. J Nucl Med (2005) 1.23

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 1.21

General consumer communication tools for improved image management and communication in medicine. J Digit Imaging (2005) 1.17

Augmented reality and image overlay navigation with OsiriX in laparoscopic and robotic surgery: not only a matter of fashion. J Hepatobiliary Pancreat Sci (2011) 1.16

Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging (2013) 1.12

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases. Acta Oncol (2013) 1.11

Frontotemporal dementia: pathology of gait? Mov Disord (2010) 1.10

Giant plexiform neurofibroma in neurofibromatosis type 1. Arch Neurol (2010) 1.09

In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage (2008) 1.08

Casimage project: a digital teaching files authoring environment. J Thorac Imaging (2004) 1.08

Whole-body hybrid PET/MRI: ready for clinical use? Eur J Nucl Med Mol Imaging (2011) 1.07

Impact of impaired executive function on gait stability. Dement Geriatr Cogn Disord (2008) 1.06

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma. Radiat Oncol (2008) 1.04

RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study. Radiat Oncol (2009) 1.04

Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics (2005) 1.03

Spinal uptake mimicking metastasis in SPECT/CT bone scan in a patient with superior vena cava obstruction. Clin Nucl Med (2013) 1.02

A lung segmentectomy performed with 3D reconstruction images available on the operating table with an iPad. Interact Cardiovasc Thorac Surg (2011) 1.02

FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging (2014) 1.00

Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging (2013) 0.99

White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol (2008) 0.99

Informatics in radiology (infoRAD): navigating the fifth dimension: innovative interface for multidimensional multimodality image navigation. Radiographics (2006) 0.98

Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study. Radiother Oncol (2009) 0.98

Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol (2004) 0.98

Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. JACC Cardiovasc Imaging (2012) 0.98

Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. Eur Heart J (2011) 0.96

Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol (2006) 0.96

First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy. Eur J Nucl Med Mol Imaging (2013) 0.94

Clinical applications of hybrid PET/MRI in neuroimaging. Clin Nucl Med (2013) 0.92

Performance evaluation of the FLEX triumph X-PET scanner using the national electrical manufacturers association NU-4 standards. J Nucl Med (2010) 0.92

F-18 fluorodeoxyglucose (FDG) PET in the diagnosis of malignant transformation of fibrous dysplasia in the pelvic bones. Clin Nucl Med (2008) 0.91

NEMA NU-04-based performance characteristics of the LabPET-8™ small animal PET scanner. Phys Med Biol (2011) 0.91

3D fat-saturated T1 SPACE sequence for the diagnosis of cervical artery dissection. Neuroradiology (2013) 0.91

Contrast-enhanced MR angiography of the chest and abdomen with use of controlled apnea in children. Radiology (2007) 0.90

Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies. MAGMA (2012) 0.90

Augmented reality to the rescue of the minimally invasive surgeon. The usefulness of the interposition of stereoscopic images in the Da Vinci™ robotic console. Int J Med Robot (2012) 0.89

Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med (2005) 0.89

Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. Eur Heart J (2013) 0.89

Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging. Eur J Nucl Med Mol Imaging (2014) 0.88

¹⁸F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer. Eur J Nucl Med Mol Imaging (2011) 0.88

Impact of metal artefacts due to EEG electrodes in brain PET/CT imaging. Phys Med Biol (2008) 0.86

Ventricular mechanical dyssynchrony and resynchronization therapy in heart failure: a new indication for Fourier analysis of gated blood-pool radionuclide ventriculography. Nucl Med Commun (2006) 0.86

Pathology of the trigeminal nerve. Neuroimaging Clin N Am (2008) 0.86

FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. J Alzheimers Dis (2012) 0.86

Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction. J Nucl Cardiol (2007) 0.86

SPECT/CT in differentiation of pseudarthrosis from other causes of back pain in lumbar spinal fusion: report on 10 consecutive cases. Clin Nucl Med (2012) 0.85

Added Value of Combined Semi-Quantitative and Visual [123I]FP-CIT SPECT Analyses for the Diagnosis of Dementia With Lewy Bodies. Clin Nucl Med (2016) 0.84

Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation. Comput Med Imaging Graph (2012) 0.84

Structured reporting: a fusion reactor hungry for fuel. Insights Imaging (2014) 0.83

Mild influenza-associated encephalopathy/encephalitis with a reversible splenial lesion in a Caucasian child with additional cerebellar features. Eur J Paediatr Neurol (2009) 0.83

Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis. J Neurol (2005) 0.83

Console-integrated stereoscopic OsiriX 3D volume-rendered images for da Vinci colorectal robotic surgery. Surg Innov (2012) 0.82

⁹⁰Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT). Eur J Nucl Med Mol Imaging (2011) 0.82

A PET-MRI case of corticocerebellar diaschisis after stroke. Clin Nucl Med (2011) 0.82

PET evidence of central GABAergic changes in stiff-person syndrome. Mov Disord (2007) 0.82

Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images. J Nucl Med (2004) 0.81

Effect of peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, on dedifferentiated thyroid cancers. Nucl Med Commun (2004) 0.81

Preliminary evidence of validity of the revised criteria for Alzheimer disease diagnosis: report of 2 cases. Alzheimer Dis Assoc Disord (2010) 0.81

The behavioural features of fatal familial insomnia: A new Italian case with pathological verification. Sleep Med (2008) 0.81

From PACS to the clouds. Eur J Radiol (2011) 0.81

Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT. Radiat Oncol (2012) 0.81

A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives. Eur J Nucl Med Mol Imaging (2015) 0.81

18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis? Clin Nucl Med (2012) 0.80

18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer. Radiother Oncol (2009) 0.80

Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia. Clin Nucl Med (2013) 0.80

Duplication of the extracranial internal carotid artery analyzed by MRI. Can J Neurol Sci (2013) 0.80

Neuroimaging of dementia in 2013: what radiologists need to know. Eur Radiol (2013) 0.79

Dual-task related gait changes after CSF tapping: a new way to identify idiopathic normal pressure hydrocephalus. J Neuroeng Rehabil (2013) 0.79

Breathing adapted radiotherapy: a 4D gating software for lung cancer. Radiat Oncol (2011) 0.79

[11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis. J Alzheimers Dis (2012) 0.79

A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset. Neurobiol Dis (2008) 0.79

Stereoscopic augmented reality for da Vincii™ robotic biliary surgery. Int J Surg Case Rep (2013) 0.78

Tracking the source of cerebellar epilepsy: hemifacial seizures associated with cerebellar cortical dysplasia. Epilepsy Res (2013) 0.78

Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia. Behav Brain Res (2013) 0.78

Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT. J Nucl Cardiol (2010) 0.78

PET radiotracers for molecular imaging in dementia. Curr Radiopharm (2013) 0.78

Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECT to MRI perfusion. J Nucl Cardiol (2009) 0.78

Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods. Melanoma Res (2003) 0.78

Is metal artefact reduction mandatory in cardiac PET/CT imaging in the presence of pacemaker and implantable cardioverter defibrillator leads? Eur J Nucl Med Mol Imaging (2010) 0.77

Positron emission tomography changes in PARK1 mutation. Mov Disord (2006) 0.77